An in vitro study investigating the role of the Shh signaling pathway in the anticancer inhibitory effect of genistein showed that genistein targeted cancer stem cells in malignant tumors, and significantly reduced the number and size of kidney cancer stem cells in a dose-dependent manner. Here, SHH is linked to cancer.